Companies Investors People

Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

Contact
Request a Demo
Request Data Updates
Add a Company

Research

Companies
Investors
People

aVenture

Download App
Pricing

Resources

Documentation
Use Cases
CLI
MCP
Feature Requests
Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading

Xenon Ophthalmics - aVenture Company Research

Xenon Ophthalmics

Xenon Ophthalmics

Xenon Ophthalmics™ Inc. is a global leader in medical-grade eyecare technology, offering innovative, cost-effective diagnostic solutions using AI, VR, and Eye-Tracking Software.

Belleville, NJ, US🇺🇸

Founded

Xenon Ophthalmics™ Inc., founded with a mission to revolutionize global eye care, is a medical device and technology company that offers advanced diagnostic screening equipment. Their flagship product, the XO Exam™ System, is a next-generation headset that integrates AI, VR, and Eye-Tracking Software to provide comprehensive and cost-effective eye examinations. The company targets Ophthalmologists, Optometrists, eyecare clinics, and primary care providers, aiming to enhance the accuracy and accessibility of eye care diagnostics worldwide.

The leadership team at Xenon Ophthalmics includes experts in medical technology and ophthalmology, supported by notable investors from the healthcare and tech industries. The company has achieved significant milestones, including the development of the world's first medical-grade ophthalmic diagnostic headset. Their innovative approach has had a substantial impact on the eyecare market, improving diagnostic capabilities and patient outcomes through cutting-edge technology.

Xenon Ophthalmics - Similar Companies

OculoMotor Technologies

Ocular Diagnostics

XOi Technologies

xoi.io

Heru

Xenon Ophthalmics - Quick Facts

Who are Xenon Ophthalmics' competitors?

Companies similar to Xenon Ophthalmics include OculoMotor Technologies, Ocular Diagnostics, XOi Technologies and Heru.

When was Xenon Ophthalmics founded?

Xenon Ophthalmics was founded in 2019.

Where is Xenon Ophthalmics' headquarters located?

Xenon Ophthalmics' headquarters is located in Belleville, NJ, US.

When was Xenon Ophthalmics' last funding round?

Xenon Ophthalmics' most recent funding round was for $300k (USD) in September 2021.

How much disclosed funding has Xenon Ophthalmics raised?

Xenon Ophthalmics - Classification

Industry: Hardware
Ownership: Venture-backed
Technology: AI
VR

As of Sep 1, 2021, Xenon Ophthalmics has disclosed funding of $1.3M (USD). Undisclosed round amounts are excluded.

How many employees does Xenon Ophthalmics have?

Xenon Ophthalmics has 30 employees as of Feb 5, 2024.

Geographic Exposure

Global

Revenue: Recurring
Software
Transactional
Customer: Enterprise
Main Product: Diagnostics
Medical Devices

Tags: Healthcare
Healthtech
Medtech

NAICS: 320000Manufacturing
325400Pharmaceutical and Medicine Manufacturing
325000Chemical Manufacturing
325410Pharmaceutical and Medicine Manufacturing
SIC: 5000Wholesale Trade-durable Goods
5040Professional And Commercial Equipment And Supplies
5047Medical, Dental, And Hospital Equipment And Supplies

Show 7 more industry codes

NAICS: 330000Manufacturing
620000Health Care and Social Assistance
623000Nursing and Residential Care Facilities
SIC: 3900Miscellaneous Manufacturing Industries
8000Health Services
8040Offices And Clinics Of Other Health Practitioners
8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified

seeheru.com

Xironetic

xironetic.com

Xoran Technologies

xorantech.com

Inseye

inseye.com

Mediview XR

Oculogica

oculogica.com

Eyebot

eyebot.tech

Bioxytech Retina

bioxytech.com

Veyond Metaverse

brinXY

Visunex Medical Systems

Optovue